The unique structure of gadopiclenol has 2 water molecule exchange sites designed to maximize the efficiency of gadolinium (Gd) so only half the conventional dose is needed1
A simple, yet innovative equation
See how Elucirem™ improves the contrast-enhanced MRI experience
Unlike most GBCAs that have 1 water molecule exchange site, Elucirem™ is designed with 2 water molecule exchange sites, which doubles the relaxivity and increases the contrast enhancement, allowing for the use of 50% less gadolinium than conventional GBCAs.1
Want to see how Elucirem™ can bring you diagnostic confidence?*
*Diagnostic confidence was a secondary criterion.
GBCA: Gadolinium-Based Contrast Agent
MRI: Magnetic Resonance Imaging
References
1. Robic C, Port M, Rousseaux O, et al. Physicochemical and Pharmacokinetic Profiles of Gadopiclenol: A New Macrocyclic Gadolinium Chelate With High T1 Relaxivity. Invest Radiol. 2019 Aug;54(8):475-484.
Click here for the SmPC. For more information, please refer to your local product information